← Leaderboards
Michael J Aminoff
University Of California San Francisco
$1,031,336
Attributed
$1,088,683
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $135.5K · FY2005–14$200K$150K$100K$50K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$1,088,683 · 4
By mechanism
U10$933,366 · 1
M01$155,317 · 3
Top collaborators
- Chad Christine2 shared
Most similar at University Of California San Francisco
Same institution · by research overlap
- Jeffrey Charles Lotz$49,562,566
- Ruth Martha Greenblatt$14,541,651
- Robert A Hiatt$19,535,143
- Sharmila Majumdar$36,277,908
- Jay Z Parrish$4,520,210
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchClinical TrialsHuman SubjectParkinson'S DiseaseNeuroprotectionNeurodegenerative DisordersParkinson DiseaseNeuroprotective AgentsCaringProspectiveHealth ServicesHuman Therapy EvaluationNeurosciencesAwardAlzheimer&AposDiagnosticAllyAnti-Inflammatory AgentsDiagnosisDiscipline Of NursingClinicClimateAnti-InflammatoryClinical Services
Grant awards (20)
Parkinson's Disease Neuroprotection Clinical Trial$38,005
U10 · FY2014 · NS · contact PI
Parkinson's Disease Neuroprotection Clinical Trial$76,690
U10 · FY2013 · NS · contact PI
Parkinson's Disease Neuroprotection Clinical Trial$81,062
U10 · FY2012 · NS · contact PI
Parkinson's Disease Neuroprotection Clinical Trial$84,382
U10 · FY2011 · NS · contact PI
Parkinson's Disease Neuroprotection Clinical Trial$92,863
U10 · FY2010 · NS · contact PI
Parkinson's Disease Neuroprotection Clinical Trial$42,600
U10 · FY2010 · NS · contact PI
Parkinson's Disease Neuroprotection Clinical Trial$98,284
U10 · FY2009 · NS · contact PI
Parkinson's Disease Neuroprotection Clinical Trial$95,672
U10 · FY2008 · NS · contact PI
Parkinson's Disease Neuroprotection Clinical Trial$73,828
U10 · FY2007 · NS · contact PI
Parkinson's Disease Neuroprotection Clinical Trial$25,200
U10 · FY2006 · NS · contact PI
A MULTICENTER, DOUBLE-BLIND, PILOT STUDY OF COQ10 AND GPI 1485 IN SUBJECTS WITH)$8,418
M01 · FY2005 · RR
MINOCYCLINE AND CREATINE IN SUBJECTS WITH EARLY UNTREATED PARKINSON'S DISEASE$5,612
M01 · FY2005 · RR
Minocycline and Creatine in Subjects With Early Untreated Parkinson's Disease$3,042
M01 · FY2004 · RR
Parkinson's Research: The Organized Genetics Initiative (PROGENI)$913
M01 · FY2004 · RR
Parkinson's Disease Neuroprotection Clinical Trial$114,102
U10 · FY2003 · NS
Parkinson's Disease Neuroprotection Clinical Trial$110,678
U10 · FY2002 · NS
CLINICAL TRIAL OF RASAGILINE MESYLATE IN EARLY PARKINSONS DISEASE$68,666
M01 · FY2002 · RR
CLINICAL TRIAL OF RASAGILINE MESYLATE IN EARLY PARKINSONS DISEASE$68,666
M01 · FY2001 · RR
CLINICAL TRIAL OF RASAGILINE MESYLATE IN EARLY PARKINSONS DISEASE$0
M01 · FY2001 · RR
CLINICAL TRIAL OF RASAGILINE MESYLATE IN EARLY PARKINSONS DISEASE$0
M01 · FY2000 · RR